cagrilintide and retatrutide stack + Cagrilintide: Quad-Pathway (2026) Retatrutide + Cagrilintide: The STRONGEST

What happens in your body after the first GLP-1 dose The moment a GLP-1 receptor agonist enters your bloodstream, a cascade begins

Once reconstituted from its lyophilised form, the peptide becomes vulnerable to hydrolysis, oxidation, aggregation, and microbial contamination making correct storage, handling, and adherence to sponsor-validated stability data essential for safety

GLP-1 constipation relief across different medications While the core strategies apply to all GLP-1 medications, there are nuances worth noting for specific drugs

Avoid using the same spot repeatedly to minimize irritation

Never mix insulin and GLP-1 agonists in the same syringe unless specifically using a combination product designed for this purpose

As with other medicines affecting GLP-1-related pathways, gastrointestinal side effects are commonly discussed